胸膜上皮瘤和免疫系统:免疫疗法的作用
Matteo Perrino1, Nadia Cordua1, Fabio De Vincenzo1
1Department of Oncology, IRCCS Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano, 20089 Milan, Italy.
Cancers
|December 9, 2023
概括
胸膜上皮瘤 (TETs) 具有独特的免疫生物学,影响免疫治疗. 这篇综述探讨了胸腺免疫,自身免疫以及当前针对这些罕见的胸部癌症的免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胸部外科手术 胸部外科手术
背景情况:
- 胸膜上皮瘤 (TETs),包括胸膜瘤和胸膜癌 (TC),是罕见的胸部癌症.
- 目前对高级或耐火TET的治疗方法有限,化疗是标准的.
- 与其他癌症相比,TET的向疗法和免疫疗法发展不足.
研究的目的:
- 审查胸腺的免疫生物学及其与自身免疫性瘤性疾病的联系.
- 总结当前免疫治疗策略的有效性和安全性,包括免疫检查点抑制剂和癌症疫苗,用于TETs.
主要方法:
- 关于胸腺免疫生物学研究的综合文献综述.
- 对皮上皮瘤免疫疗法临床试验数据的分析.
- 检查TETs,自身免疫和免疫治疗结果之间的关系.
主要成果:
- 胸腺瘤具有独特的免疫特征,这是由于胸腺在免疫耐受性中的作用.
- 免疫疗法,特别是免疫检查点抑制剂,在TET中表现出临床活性,但与免疫相关的副作用增加有关.
- TETs,自身免疫和免疫治疗之间的相互作用需要进一步研究.
结论:
- 了解TETs的免疫机制对于推进免疫治疗至关重要.
- 需要生物标志物来预测反应和毒性,优化胸腺瘤和胸腺癌患者的免疫治疗.
- 对胸腺免疫和定制免疫治疗方法的进一步研究对于改善罕见胸部癌症的结果至关重要.
关键词:
生物标志物 生物标志物癌症疫苗 癌症疫苗免疫检查点抑制剂 免疫检查点抑制剂免疫耐受性 免疫耐受性与免疫相关的不良事件.胸腺癌 (thymic carcinoma) 是一种癌症.胸膜上皮瘤 胸膜上皮瘤蒂莫莫马马 (thymomaoma) 是一种疾病.更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
774
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
